Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial [see comments]. - Burris,H.A.; Moore,M.J.; Andersen,J.; Green,M.R.; Rothenberg,M.L.; Modiano,M.R. (J Clin Oncol, 1997)